ReCross – When Two Worlds Meet

Published: 18 May 2021

  • Views:

    Views Icon 10006
  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

Through the case experience of an international faculty of CTO PCI experts, the emerging understanding of the everyday efficiency of the unique ReCross dual OTW lumen microcatheter is demonstrated.

 

The experts consider their personal CTO PCI algorithms, and how they believe ReCross’s versatility allows the device to contribute to antegrade success in the widely recognised EuroCTO Club and Hybrid algorithms respectively. 

This programme is supported by:

Key Learning Objectives

  • Understand the versatility of the unique ReCross dual OTW microcatheter in CTO PCI
  • Discover, via case demonstrations, how the ReCross device creates a bridge between commonly used CTO PCI algorithms, for example EuroCTO and Hybrid
  • Learn from CTO PCI experts how, in their experience, there is a potential to increase antegrade success rates with this device
  • Learn how the accessible versatility of ReCross has the potential role for operators expanding their skill set from Antegrade Wire Escalation to parallel wiring and ADR

Faculty

  • Dr Farouc Jaffer
  • Dr Alexandre Avran
  • Dr Andrew Lucking
  • Dr Emmanouil Brilakis
  • Dr Elliot Smith
  • Dr Roberto Garbo
  • Dr Ajay Kirtane
  • Dr Margaret McEntegart
  • Dr Gabriele Gasparini

More from this programme

Part 2

When Two Worlds Meet 2

An expert discussion on the new catheter technology ReCross and the impact it has had in coronary CTO's, changing the way physicians think and approach CTO interventions with Dr Garbo, Dr Brilakis and Dr Smith.

Faculty Biographies

Farouc Jaffer

Farouc Jaffer

Director, Coronary Intervention

Dr Jaffer is Associate Professor of Medicine at Harvard Medical School and an Interventional Cardiologist at Massachusetts General Hospital. He is Director of Coronary Intervention and Director of the Chronic Total Occlusion (CTO) PCI Program at Massachusetts General Hospital.


Dr Jaffer is also a Principal Investigator in the MGH Cardiovascular Research Center where his NIH-funded laboratory develops novel molecular imaging approaches to image high-risk plaques and blood clots, to better prevent heart attacks, strokes, and venous blood clots.

View full profile
Andrew Lucking

Andrew Lucking

Interventional Cardiologist

Dr Andrew Lucking is an Interventional Cardiologist at the John Radcliffe Hospital, Oxford. He has extensive experience in cardiac catheterization and intervention, primary PCI, CTO, and intravascular imaging with IVUS and OCT.


Dr Lucking has a well-established background in clinical research in interventional cardiology and is an expert in inflammatory mediators, thrombosis, and vascular injury after PCI and STEMI.

View full profile